Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 64

1.

Malaria vaccine trials--beyond efficacy end points.

Daily JP.

N Engl J Med. 2012 Dec 13;367(24):2349-51. doi: 10.1056/NEJMe1213392. Epub 2012 Nov 9. No abstract available.

PMID:
23136910
2.

[Molecular strategy for parasitism and vaccine development of falciparum malaria].

Horii T.

Tanpakushitsu Kakusan Koso. 2001 Dec;46(15):2154-62. Review. Japanese. No abstract available.

PMID:
11762075
3.

An efficacy trial of the malaria vaccine SPf66 in Gambian infants--second year of follow-up.

Bojang KA, Obaro SK, D'Alessandro U, Bennett S, Langerock P, Targett GA, Greenwood BM.

Vaccine. 1998 Jan;16(1):62-7.

PMID:
9607010
4.

[A synthetic vaccine against Plasmodium falciparum].

Fleischer B.

Dtsch Med Wochenschr. 1993 Sep 24;118(38):1385-6. German. No abstract available.

PMID:
8404485
5.

Field trials of an asexual blood stage malaria vaccine: studies of the synthetic peptide polymer SPf66 in Thailand and the analytic plan for a phase IIb efficacy study.

Ballou WR, Blood J, Chongsuphajaissidhi T, Gordon DM, Heppner DG, Kyle DE, Luxemburger C, Nosten F, Sadoff JC, Singhasivanon P, et al.

Parasitology. 1995;110 Suppl:S25-36.

PMID:
7784126
6.

Duration of protection and age-dependence of the effects of the SPf66 malaria vaccine in African children exposed to intense transmission of Plasmodium falciparum.

Alonso PL, Smith TA, Armstrong-Schellenberg JR, Kitua AY, Masanja H, Hayes R, Hurt N, Font F, Menendez C, Kilama WL, Tanner M.

J Infect Dis. 1996 Aug;174(2):367-72.

PMID:
8699068
7.

Malaria vaccine trials: the missing qualitative data.

Ferreira M.

Immunol Cell Biol. 1996 Aug;74(4):301-5. Review.

8.

The development of malaria vaccines: SPf66--what next?

Tanner M, Alonso PL.

Schweiz Med Wochenschr. 1996 Jul 9;126(27-28):1210-5.

PMID:
8766632
9.

A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS,S Malaria Vaccine Evaluation Group.

Stoute JA, Slaoui M, Heppner DG, Momin P, Kester KE, Desmons P, Wellde BT, Garçon N, Krzych U, Marchand M.

N Engl J Med. 1997 Jan 9;336(2):86-91.

10.

Malaria. A complex new vaccine shows promise.

Vogel G.

Science. 2004 Oct 22;306(5696):587-9. No abstract available.

PMID:
15498976
11.

A recombinant circumsporozoite protein vaccine against malaria.

Bloom BR.

N Engl J Med. 1997 Jun 12;336(24):1760; author reply 1760-1. No abstract available.

PMID:
9182222
12.

A population-based clinical trial with the SPf66 synthetic Plasmodium falciparum malaria vaccine in Venezuela.

Noya O, Gabaldón Berti Y, Alarcón de Noya B, Borges R, Zerpa N, Urbáez JD, Madonna A, Garrido E, Jimenéz MA, Borges RE, et al.

J Infect Dis. 1994 Aug;170(2):396-402.

PMID:
8035026
13.

Pre-erythrocytic malaria vaccines to prevent Plasmodium falciparum malaria.

Ballou WR, Kester KE, Heppner DG.

Chem Immunol. 2002;80:253-61. Review. No abstract available.

PMID:
12058643
14.

[NANP]19-5.1. A malaria vaccine field trial in Nigerian children.

Reber-Liske R, Salako LA, Matile H, Sowunmi A, Stürchler D.

Trop Geogr Med. 1995;47(2):61-3.

PMID:
8592764
15.

The case for a subunit vaccine against malaria.

Anders RF.

Trends Parasitol. 2011 Aug;27(8):330-4. doi: 10.1016/j.pt.2011.04.003. Epub 2011 May 17.

PMID:
21592861
16.

Malaria vaccines--now and the future.

Targett GA.

Trans R Soc Trop Med Hyg. 1995 Nov-Dec;89(6):585-7. Review. No abstract available.

PMID:
8594664
17.

Serious setback for Patarroyo vaccine.

Marshall E.

Science. 1996 Sep 20;273(5282):1652. No abstract available.

PMID:
8830407
18.

Humoral immune responses during a malaria vaccine trial in Tanzanian infants.

Galindo CM, Acosta CJ, Schellenberg D, Aponte JJ, Roca A, Oettli A, Urassa H, Armstrong Schellenberg J, Kahigwa E, Ascaso C, Mshinda H, Lwilla F, Vidal J, Menendez C, Tanner M, Alonso PL.

Parasite Immunol. 2000 Sep;22(9):437-43.

19.

A trial of the synthetic malaria vaccine SPf66 in Tanzania: rationale and design.

Alonso PL, Tanner M, Smith T, Hayes RJ, Schellenberg JA, Lopez MC, Bastos de Azevedo I, Menendez C, Lyimo E, Weiss N, et al.

Vaccine. 1994 Feb;12(2):181-6.

PMID:
8147101
20.

Progress in the development of recombinant and synthetic blood-stage malaria vaccines.

Mahanty S, Saul A, Miller LH.

J Exp Biol. 2003 Nov;206(Pt 21):3781-8. Review.

Supplemental Content

Support Center